HIV Prevention England Conference 2024 – presentations and talks

Nearly 300 delegates attended the HIV Prevention England Conference 2024, a one-day conference focussing on equity and impact in HIV prevention. The conference brought together community organisations, commissioners, clinicians and the private sector for vital conversations during this time of change in HIV prevention.

The question of how to end new cases of HIV ran throughout the conference, from the opening address of Andrew Gwynne MP (Minister for Public Health and Prevention) where he confirmed a new HIV action plan will be published next year, to the closing plenary panel discussion on the practical steps to the 2030 goal.

You can view the slides and watch selected sessions below, including our opening and closing plenaries.


Opening plenary

Speakers:

  • Richard Angell OBE, Terrence Higgins Trust
  • Andrew Gwynne MP, Minister for Public Health and Prevention
  • Professor Kevin Fenton, Department for Health and Social Care
  • Memory Sachikonye, UK-CAB


Insights into PrEP awareness and need

Chair : Catherine Dodds


Impactful approaches to address HIV stigma


Sexual health knowledge and key populations


Opt-out testing for HIV in emergency departments


Achieving equitable access to PrEP


Experiences of navigating health systems for Black African and Caribbean communities


Making an impact in re-engagement and retention in care


Developing better insights to achieve equity for underserved communities


Working in partnership for impact


Getting to zero by 2030. How do we make it a reality?

Closing plenary panel discussion.

Chair: Ian Jackson

Panellists: Christina Ganotakis (One Voice Network), Prof Claudia Estcourt (BASHH), James Woolgar (English Sexual Health Commissioners Group), Adam Winter (Department of Health and Social Care), Rachel Hill-Tout (NHS England – BBV Clinical Lead), Richard Angell OBE (Terrence Higgins Trust) & Sinead Ward (ViiV Healthcare)


The conference is organised by Terrence Higgins Trust for HIV Prevention England, which is commissioned by the Departments of Health and Social Care. Many thanks to our sponsors: Pasante Healthcare, ViiV Healthcare and, our lead sponsor, Gilead Sciences.